Marta Pozniak
Overview
Explore the profile of Marta Pozniak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
72
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zukowska D, Chorazewska A, Ciura K, Gedaj A, Kalka M, Pozniak M, et al.
Cell Commun Signal
. 2024 May;
22(1):270.
PMID: 38750548
Fibroblast growth factor receptor 1 (FGFR1) is a N-glycosylated cell surface receptor tyrosine kinase, which upon recognition of specific extracellular ligands, fibroblast growth factors (FGFs), initiates an intracellular signaling. FGFR1...
2.
Gedaj A, Zukowska D, Porebska N, Pozniak M, Krzyscik M, Czyrek A, et al.
Cell Commun Signal
. 2023 Jun;
21(1):129.
PMID: 37312124
No abstract available.
3.
Gedaj A, Zukowska D, Porebska N, Pozniak M, Krzyscik M, Czyrek A, et al.
Cell Commun Signal
. 2023 May;
21(1):122.
PMID: 37231412
Fibroblast growth factors (FGFs) and their receptors (FGFRs) constitute complex signaling hubs that are crucial for the development and homeostasis of the human body. Most of FGFs are released by...
4.
Zukowska D, Gedaj A, Porebska N, Pozniak M, Krzyscik M, Czyrek A, et al.
Cell Mol Life Sci
. 2023 Apr;
80(4):113.
PMID: 37012400
FGF/FGFR signaling is critical for the development and homeostasis of the human body and imbalanced FGF/FGFR contributes to the progression of severe diseases, including cancers. FGFRs are N-glycosylated, but the...
5.
Pozniak M, Zukowska D, Gedaj A, Krzyscik M, Porebska N, Zakrzewska M, et al.
Int J Mol Sci
. 2022 Aug;
23(15).
PMID: 35955648
Precise anticancer therapies employing cytotoxic conjugates constitute a side-effect-limited, highly attractive alternative to commonly used cancer treatment modalities, such as conventional chemotherapy, radiotherapy or surgical interventions. Receptor tyrosine kinases are...
6.
Porebska N, Knapik A, Pozniak M, Krzyscik M, Zakrzewska M, Otlewski J, et al.
Biomacromolecules
. 2021 Dec;
22(12):5349-5362.
PMID: 34855396
Fibroblast growth factor receptor 1 (FGFR1) is an integral membrane protein that transmits prolife signals through the plasma membrane. Overexpression of FGFR1 has been reported in various tumor types, and...
7.
Pozniak M, Porebska N, Jastrzebski K, Krzyscik M, Kucinska M, Zarzycka W, et al.
J Biomed Sci
. 2021 Oct;
28(1):69.
PMID: 34635096
Background: Overexpression of FGFR1 is observed in numerous tumors and therefore this receptor constitutes an attractive molecular target for selective cancer treatment with cytotoxic conjugates. The success of cancer therapy...
8.
Pozniak M, Zarzycka W, Porebska N, Knapik A, Marczakiewicz-Perera P, Zakrzewska M, et al.
Biomolecules
. 2021 Aug;
11(8).
PMID: 34439755
FGFRs are cell surface receptors that, when activated by specific FGFs ligands, transmit signals through the plasma membrane, regulating key cellular processes such as differentiation, division, motility, metabolism and death....
9.
Pozniak M, Porebska N, Krzyscik M, Sokolowska-Wedzina A, Jastrzebski K, Sochacka M, et al.
Mol Med
. 2021 May;
27(1):46.
PMID: 33962559
Background: Antibody drug conjugates (ADCs) represent one of the most promising approaches in the current immuno-oncology research. The precise delivery of cytotoxic drugs to the cancer cells using ADCs specific...
10.
Porebska N, Pozniak M, Matynia A, Zukowska D, Zakrzewska M, Otlewski J, et al.
Cytokine Growth Factor Rev
. 2021 Apr;
60:89-106.
PMID: 33863623
Receptor tyrosine kinases (RTKs) constitute a large group of cell surface proteins that mediate communication of cells with extracellular environment. RTKs recognize external signals and transfer information to the cell...